Skevaki Chrysanthi, Ngocho James S, Amour Caroline, Schmid-Grendelmeier Peter, Mmbaga Blandina T, Renz Harald
Institute of Laboratory Medicine, Universities of Giessen and Marburg Lung Center, Philipps Universität Marburg, Member of the German Center for Lung Research, Marburg, Germany.
Department of Epidemiology and Applied Biostatistics, Kilimanjaro Christian Medical University College, Moshi, Tanzania.
J Allergy Clin Immunol. 2021 Dec;148(6):1378-1386. doi: 10.1016/j.jaci.2021.10.019. Epub 2021 Oct 27.
Sub-Saharan Africa (SSA) is currently undergoing a transformation process of unprecedented magnitude owing to economic development and urbanization. This process is paralleled by a dramatic increase in prevalence and incidence of noncommunicable diseases. In this article we analyze the current situation with regard to 1 group of the earliest noncommunicable diseases in a person's life, namely, allergies and asthma. This article provides an update on the epidemiology, availability, and access to management strategies by patients experiencing bronchial asthma or atopic dermatitis in SSA. Despite all of the progress, there is still a tremendous need to support education and training, transfer of resources, and cooperation with pharmaceutical and diagnostic companies to achieve adequate treatment and sustainability in SSA with regard to allergy, asthma, and eczema management.
由于经济发展和城市化，撒哈拉以南非洲（SSA）目前正在经历一场规模空前的转型过程。与此同时，非传染性疾病的患病率和发病率急剧上升。在本文中，我们分析了人生中最早出现的一类非传染性疾病，即过敏和哮喘的现状。本文提供了关于撒哈拉以南非洲地区支气管哮喘或特应性皮炎患者的流行病学、管理策略的可及性和获取情况的最新信息。尽管取得了所有这些进展，但仍迫切需要支持教育和培训、资源转移以及与制药和诊断公司的合作，以在撒哈拉以南非洲地区实现对过敏、哮喘和湿疹管理的充分治疗和可持续性。
